Document:

Exhibit 4.1

 

RECIPIENT _________________________

 

SUBSCRIPTION INSTRUCTIONS

 

By accepting delivery of this Subscription
Agreement, you agree to return it and all related documents you receive to ImmuDyne, Inc. if you decide not to subscribe to purchase
the securities offered. Distribution of the subscription materials to any person other than the person named above (or to individuals
retained to advise him, her or it with respect thereto) is unauthorized, and any reproduction thereof or the divulgence of any
of their contents without the prior written consent of ImmuDyne, Inc. is prohibited.

 

Investors interested in making an investment in ImmuDyne, Inc.
should:

 

		(1)	date, sign and complete the information requested on the signature page to the attached Subscription Agreement,

 

		(2)	complete and sign the accompanying Certificate of Accredited Investor Status,

 

		(3)	submit a check for the Subscription Amount made payable to ImmuDyne, Inc. to the address indicated in (4) below or transmit
funds via wire to the following account:

 

____________________ Bank

ABA:  _______________

For Credit to:  ImmuDyne, Inc.

Account No.:  ______________________

 

		(4)	send all completed documents to:

 

ImmuDyne, Inc.

50 Spring Meadow Road

Mt. Kisco, New York 10549

Attn: Mr. Mark McLaughlin

Phone (U.S.): 914-244-1777

Phone (International): +1 914-244-1777

Fax (U.S.): 914-244-8576

Fax (International): +1 914-244-8576

 

ATTENTION SUBSCRIBERS: NO SUBSCRIPTION
WILL BE ACCEPTED UNLESS ALL DOCUMENTATION PRESCRIBED HEREIN IS FULLY COMPLETED AND EXECUTED. ANY MATERIALS RECEIVED THAT ARE INCOMPLETE
IN ANY RESPECT WILL BE RETURNED BY THE SELLER.

 

    	-1-

    	 

    

 

SUBSCRIPTION AGREEMENT

 

THIS SUBSCRIPTION AGREEMENT
(the “Agreement”) dated as of the date set forth below by and between ImmuDyne, Inc., a Delaware corporation (the “Seller”),
and the undersigned (the “Subscriber”), sets forth certain representations, covenants and agreements between Seller
and Subscriber, with respect to the offering (the “Offering”) for sale by Seller of up to 3,000,000 shares of Stock,
par value $.01 per share (the “Stock”), and warrants to purchase up to 1,500,000 shares of Stock (the “Warrants”).
The Warrants are paired with the Stock on the basis of one Warrant for every two shares of Stock purchased, are exercisable at
any time prior to the third anniversary of their issuance at $0.40 per share and are otherwise subject to the terms and conditions
set forth in the form of Warrant attached hereto as Exhibit B.

 

1.          Subscription.
Subject to the terms and conditions hereof, Subscriber hereby irrevocably subscribes for and agrees to purchase from Seller the
number of shares of Stock and Warrants (collectively, the “Units”) set forth under its name on the signature page hereto
at a purchase price of $0.17 per Unit (the “Offering Price”). In reliance upon the representations and warranties of
Subscriber contained herein, Seller agrees to sell such Units to Subscriber at the Offering Price upon the acceptance of the subscription
as evidenced by the execution of this Agreement by an officer of Seller. This Agreement may not be terminated before the acceptance
or rejection hereof by Seller in accordance with this Agreement, unless otherwise required by applicable state law.

 

2.          Delivery
of Subscription Amount; Acceptance of Subscription; Delivery of Units. Subscriber understands and agrees that this subscription
is made subject to the following terms and conditions:

 

(a)          Subscriber
understands that separate subscription agreements will be executed with other Subscribers for up to 3,000,000 Units to be sold
in the Offering;

 

(b)          The
subscription for Units shall be deemed to be accepted only when this Agreement has been signed by an authorized officer of Seller;
the deposit of the Subscription Amount for clearance will not be deemed an acceptance of this Agreement;

 

(c)          Seller
shall have the right to allocate Units among subscribers in any manner it may desire, or to increase the maximum amount of Units
in the Offering, in the event of an oversubscription;

 

(d)          The
payment of the Subscription Amount will be returned promptly, without interest, if Subscriber’s subscription is rejected
in whole or in part or if the Offering is withdrawn or canceled, which Seller may determine to do in its sole discretion;

 

(e)          Seller
may, once subscriptions for a minimum of $100,300, or 590,000 shares, have been received, accept any subscriptions then in its
receipt (each a “Closing”) until all 3,000,000 Units offered hereby are sold;

 

    	 

    	 

    

 

(f)          Certificates
representing the shares of Stock and the Warrants purchased will be issued in the name of each Subscriber within 14 days of each
Closing;

 

(g)          The
representations and warranties of Seller and Subscriber set forth herein shall be true and correct as of the date that Seller accepts
this subscription, and Subscriber agrees to furnish Seller such other information as Seller may reasonably request in order to
verify the accuracy of the information contained herein and to notify Seller immediately of any material change in the information
provided herein that occurs prior to Seller’s acceptance of this Agreement; and

 

(h)          Contemporaneously
with the execution and delivery of this Agreement, Subscriber shall execute and deliver the Certificate of Accredited Investor
Status, and shall submit payment in the form of a check made payable to ImmuDyne, Inc. or wire to Seller, to hold in a non-interest
bearing account, immediately available funds in the amount equal to the Offering Price multiplied by the number of Units for which
Subscriber has subscribed (the “Subscription Amount”) in accordance with the Subscription Instructions attached to
this Agreement.

 

3.          Terms
of Subscription. The subscription period will begin on December 1, 2008 and will continue until December 23, 2010, unless extended
by Seller in its sole discretion. Except as required by law, Subscriber is not entitled to cancel, terminate or revoke this Agreement
or any related agreements of Subscriber hereunder. This Agreement and such other agreements shall survive the death or disability
of Subscriber and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors,
legal representatives and permitted assigns. If Subscriber is more than one person, the obligations of Subscriber hereunder shall
be joint and several, and the agreements, representations, warranties and acknowledgments herein contained shall be deemed to be
made by and be binding upon each such person. If Subscriber is not a United States citizen, Subscriber hereby represents that it
has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for
the Units or any use of this Agreement, including (i) the legal requirements within its jurisdiction for the purchase of the Units,
(ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be
obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption,
sale or transfer of the Units.

 

4.          Representations
and Warranties of Subscriber. Subscriber hereby represents and warrants to Seller and each other person who is, or in the future
becomes, a shareholder of Seller as follows:

 

(a)          Subscriber
is acquiring the Units for its own account, for investment and not with a view to, or for resale in connection with, any distribution
or public offering thereof within the meaning of the Securities Act and applicable state securities laws;

 

    	-2-

    	 

    

 

(b)          Subscriber
understands that (i) the Units (A) have not been registered under the Securities Act or any state securities laws, (B) will be
issued in reliance upon an exemption from the registration and prospectus delivery requirements of the Securities Act pursuant
to Section 4(2) and/or Regulation D thereof, and (C) will be issued in reliance upon exemptions from the registration and prospectus
delivery requirements of state securities laws which relate to private offerings, and (ii) Subscriber must therefore bear the economic
risk of such investment indefinitely unless a subsequent disposition thereof is registered under the Securities Act and applicable
state securities laws or is exempt therefrom under Rule 144 of the Securities Act. Subscriber further understands that such exemptions
depend upon, among other things, the bona fide nature of the investment intent of Subscriber expressed herein.

 

(c)          Seller
has made available to Subscriber, and Subscriber has reviewed to the extent it deemed necessary, all information regarding the
business and financial condition of Seller, its expected plans for future business activities, the status of its litigation, and
the merits and risks of an investment in the Units, considered necessary or appropriate by it in order to make an informed investment
decision regarding a purchase of the Units, including the following: its Articles of Incorporation and Bylaws, its tax returns
for the last three calendar years, the description of its products and operations on the website of Seller at www.immudyne.com
and in the Opportunity Summary prepared by Venture 2, and its trading information and capitalization at www.otcmarkets.com, call
letters IMMD (collectively, the “Disclosure Materials”), and Subscriber has had the opportunity to request and/or discuss
with representatives of Seller any other information deemed necessary or appropriate by Subscriber in order to make an informed
investment decision regarding the purchase of the Units at the Offering Price. Subscriber acknowledges that all documents, records
or books of Seller have been made available for inspection by Subscriber or Subscriber’s attorney, accountant or other representative
or agent; that Subscriber or Subscriber’s attorney, accountant or other representative or agent has for a reasonable amount
of time had an opportunity to ask questions of and receive answers from Seller concerning its proposed business and prospects;
and that all of such questions have been answered to the full satisfaction of Subscriber.

 

(d)          Subscriber
has knowledge, skill and experience in financial, business and investment matters relating to an investment of this type and is
capable of evaluating the merits and risks of such investment and protecting its interest in connection with the acquisition of
the Units. To the extent deemed necessary by Subscriber, Subscriber has retained, at its own expense, and relied upon, appropriate
professional advice regarding the investment, tax and legal merits and consequences of purchasing and owning the Units and their
suitability for Subscriber. Subscriber has the ability to bear the economic risks of its investment in Seller, including a complete
loss of the investment, and has no need for liquidity in such investment. Subscriber understands that the acquisition of the Units
is a speculative investment that involves substantial risks and that Subscriber could lose its entire investment in the Units.
Subscriber has carefully read and considered particularly the following risks peculiar to Seller, which list does not purport to
be complete:

 

(i)          The
Offering Price is not necessarily based on recent trading prices or any asset or earnings valuation per share of Seller’s
Stock on the Warrant, but has been determined by the Board of Directors of Seller to represent the fair market value of a Unit.

 

    	-3-

    	 

    

 

(ii)         Seller
may issue additional shares of Stock at prices that management deems appropriate but may be less than the Offering Price per Unit
paid by Subscribers. In addition, Seller may create and issue additional classes of capital stock with rights, priorities and liquidation
premiums different or greater than those held by Subscribers. The issuance of additional shares of Stock may dilute the ownership
interest of Subscribers in Seller.

 

(iii)        The
business of Seller is dependent on the services of Mr. Mark McLaughlin, its President, and Chief Executive Officer, and Sven Rohmann,
M.D., PhD, its Chief Medical Officer, each of whom possesses significant expertise and knowledge regarding the business of Seller.
Seller does not have an employment agreement with either Mr. McLaughlin or Dr. Dr. Rohmann, nor does it carry key man life insurance
on either of them. Any loss or interruption of the services of either of them could significantly reduce Seller’s ability
to manage effectively its business, and an appropriate replacement may not be readily obtained should the need arise.

 

(iv)        There
is only a limited public market for the Stock, so there can be no assurance that Subscriber will be able to sell or dispose of
the shares of Stock, or shares into which the Warrants are converted, at any time. Subscriber must hold the shares for at least
six months, and any public disposition thereafter must be made in compliance with Rule 144 under the Securities Act of 1933. Seller
is under no obligation to make the provisions of Rule 144 available to Subscriber; therefore a Subscriber must be able to bear
the economic risk of the investment for an indefinite period of time.

 

(v)         Although
Seller recently completed successfully a major trial regarding the ownership of patents, the defendant has filed a notice of appeal.
In addition, there can be no assurance that new litigation will not arise on related patent issues. Certain litigation involving
Seller’s patents is still pending, although Seller had been advised by counsel that the outcome should have an immaterial
effect on its business.

 

(vi)        Many
other companies offering nutritional supplements and skin car products are larger and have greater resources than Seller. These
competitors are better able to withstand industry downturns, compete on the basis of price, market their products to a broader
base and develop new products and technologies, all of which could affect our revenue and profitability.

 

(vii)       Seller’s
products are currently regulated by the Dietary Supplement Health and Education Act of 1994 which requires certain labeling but
does not require FDA approval processes as for drugs. If regulations are extended to cover Seller’s products, the costs associated
with marketing Seller’s products will increase.

 

(e)          In
making this investment decision, Subscriber is relying solely on the Disclosure Materials and investigations made by it and its
representatives. The offer to purchase the Units was communicated to Subscriber in such a manner that it was able to ask questions
of and receive answers from the management of Seller concerning the terms and conditions of the proposed transaction, and at no
time was Subscriber presented with or solicited by or through any advertisement, article, leaflet, public promotional meeting,
notice or other communication published in any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or meeting or any other form of general or public advertising or solicitation.

 

    	-4-

    	 

    

 

(f)          Subscriber
acknowledges that it has been advised that the Units offered hereby have not been approved or disapproved by the SEC or any state
securities commission, nor has the SEC or any state securities commission passed upon the accuracy or adequacy of any representations
by Seller. The Units have not been recommended or endorsed by any federal or state securities commission or regulatory authority,
nor have such authorities confirmed the accuracy or determined the adequacy of any representation.

 

(g)          Subscriber
acknowledges and is aware that there has never been any representation, guarantee or warranty made by Seller or any officer, director,
employee, agent or representative of Seller, expressly or by implication, as to (i) the approximate or exact length of time that
Subscriber will be required to remain a shareholder of Seller; (ii) the percentage of gain or loss to be realized, if any, as a
result of this investment; (iii) when or if the price per share of Stock will make conversion of the Warrants economically feasible;
or (iv) that the past performance or experience on the part of Seller, or any future expectations, will in any way indicate the
predictable results of the ownership of Units or of the overall financial performance of Seller;

 

(h)          Subscriber
represents and warrants that it is an “accredited investor” within the meaning of Rule 501 of Regulation D under the
Securities Act, and Subscriber has executed the Certificate of Accredited Investor Status, attached hereto as Exhibit A.

 

(i)          Subscriber’s
subscription and payment for, and its continued beneficial ownership of the Units, will not violate any applicable securities or
other law, nor result in the breach of or constitute a default under any agreement, instrument, law or court decree to which Subscriber
is a party or by which it is bound.

 

(j)          If
Subscriber is a natural person, Subscriber has reached the age of majority in the state in which Subscriber resides, maintains
his or her domicile at the address shown on the signature page hereof, and the funds provided for acquiring the Units are either
separate property or community property over which Subscriber has the right of control or are otherwise funds as to which it has
the sole right of management.

 

(k)          If
this Agreement is executed and delivered on behalf of a partnership, corporation, trust, estate or other entity (an “Entity”):
(i) such Entity has the full legal right and power and all authority and approval required to execute and deliver, or authorize
execution and delivery of, this Agreement and all other instruments executed and delivered by or on behalf of such Entity in connection
with the purchase of the Units and to purchase and hold such Units, (ii) the signature of the party signing on behalf of such Entity
is binding upon such Entity; and (iii) such Entity has not been formed for the specific purpose of acquiring such Units, unless
each beneficial owner of such entity is qualified as an accredited investor within the meaning of Rule 501(a) of Regulation D promulgated
under the Securities Act and has submitted information substantiating such individual qualification.

 

    	-5-

    	 

    

 

(l)          If
Subscriber is a retirement plan or is investing on behalf of a retirement plan, Subscriber acknowledges that investment in the
Stock poses additional risks including the inability to use losses generated by an investment in the Stock to offset taxable income.

 

5.          Representations
and Warranties of Seller. Seller hereby represents and warrants to Subscriber as follows:

 

(a)          Seller
is duly incorporated, validly existing and in good standing under the laws of Delaware, and is duly qualified to do business as
a foreign corporation in all jurisdictions in which the failure to be so qualified would materially and adversely affect the business
or financial condition, properties or operations of Seller.

 

(b)          Seller
has duly authorized the issuance and sale of the Units in accordance with the terms of this Agreement by all requisite corporate
action, and the execution, delivery and performance of any other agreements and instruments executed in connection herewith. This
Agreement constitutes a valid and legally binding obligation of Seller, enforceable in accordance with its terms, except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies, and (iii) to the extent the indemnification provisions contained herein may be limited by
applicable federal or state securities laws.

 

(c)          The
proceeds from the Offering will be used by Seller for general working capital purposes including marketing and expenses of litigation
to protect its intellectual property.

 

(d)          The
Disclosure Materials do not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading.

 

6.          Confidentiality.
Subscriber understands, acknowledges and agrees with Seller that certain of the information disclosed to Subscriber in connection
with this investment decision may be confidential and non-public and agrees that all such information shall be kept in confidence
by Subscriber and neither used for its personal benefit (other than in connection with this subscription) nor disclosed to any
third party for any reason; provided, however, that this confidentiality obligation shall not apply to any such information that
(i) is part of the public knowledge or literature, (ii) becomes part of the public knowledge or literature (except as a result
of a breach of this provision) or (iii) is received from third parties (except third parties who disclose such information in violation
of any confidentiality agreements or obligations, including, without limitation, any subscription agreement entered into with Seller).
In addition, Subscriber may disclose any information as may be required by law or applicable legal process; provided, however,
to the extent permitted by law or applicable legal process, Subscriber shall provide Seller at least five business days prior written
notice before making any such disclosure.

 

    	-6-

    	 

    

 

7.          Stock
and Warrant Certificates. Subscriber acknowledges that it may not, directly or indirectly, assign, transfer, offer, sell, pledge,
hypothecate, grant an option to purchase, make any short sale or otherwise dispose of or hedge all or any part of either the Stock
or the Warrants (or solicit any offers to buy, purchase or otherwise acquire or take a pledge of all or any part thereof) except
in accordance with the registration provisions of the Securities Act or an exemption from such registration provisions, and any
applicable state or other securities laws. As a result, the certificates representing the shares of Stock and the Warrants acquired
by Subscriber shall bear a restrictive legend substantially as follows:

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND STATE SECURITIES
LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE
APPLICABLE SECURITIES LAWS OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL ARE BOTH REASONABLY SATISFACTORY TO THE COMPANY,
HAS BEEN DELIVERED TO THE COMPANY STATING THAT THE SECURITIES MAY BE TRANSFERRED WITHOUT SUCH REGISTRATION.”

 

8.          Survival;
Indemnification. All representations, warranties and covenants contained in this Agreement and the indemnification contained
in this Section 8 shall survive (i) the acceptance of this Agreement by Seller, (ii) changes in the transactions, documents and
instruments described herein which are not material or which are to the benefit of Subscriber, and (iii) the death or disability
of Subscriber. Subscriber acknowledges the meaning and legal consequences of the representations, warranties and covenants in Section
4 hereof and that Seller has relied upon such representations, warranties and covenants in determining Subscriber’s qualification
and suitability to purchase the Units. Subscriber hereby agrees to indemnify, defend and hold harmless Seller, its officers, directors,
employees, agents and controlling persons, from and against any and all losses, claims, damages, liabilities, expenses (including
attorneys’ fees and disbursements), judgments or amounts paid in settlement of actions arising out of or resulting from the
untruth of any representation of Subscriber herein or the breach of any warranty or covenant herein by Subscriber. Notwithstanding
the foregoing, however, no representation, warranty, covenant or acknowledgment made herein by Subscriber shall in any manner be
deemed to constitute a waiver of any rights granted to it under the Securities Act or state securities laws.

 

9.          Notices.
All notices, consents, demands or other communications required or permitted to be given pursuant to this Agreement shall be deemed
sufficiently given when delivered by facsimile transmission, confirmed in writing, by overnight delivery service, or three business
days after the posting thereof by first class mail, postage prepaid, to the appropriate party at its address set forth on the signature
page hereof or at such other address as any party shall have specified by notice in writing to the others.

 

    	-7-

    	 

    

 

10.         Amendment.
This Agreement may not be modified, waived or terminated except by an instrument in writing signed by the party against whom enforcement
of such modification, waiver or termination is sought.

 

11.         Binding
Effect. Except as otherwise provided herein, this Agreement shall be binding upon and inure to the benefit of the parties and
their heirs, executors, administrators, successors, legal representatives and assigns, and the agreements, representations, warranties
and acknowledgments contained herein shall be deemed to be made by and be binding upon such heirs, executors, administrators, successors,
legal representatives and assigns.

 

12.         Entire
Agreement. This Agreement, including the Exhibits hereto, constitutes the entire agreement of Subscriber and Seller relating
to the matters contained herein, superseding all prior contracts or agreements, whether oral or written.

 

13.         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard
to the principles of conflicts of law thereof that would require the application of the laws of any jurisdiction other than Delaware.
In addition, the laws of the State of Delaware shall apply to any claims brought by any parties hereto which relate to the Offering,
whether or not such claim is based on contract law. Each party to this Agreement hereby irrevocably agrees that any legal action
or proceeding arising out of or relating to this Agreement or any agreements or transactions contemplated hereby shall be brought
in the courts of the State of Delaware or of the United States of America for the District of Delaware and hereby expressly submits
to the personal jurisdiction and venue of such courts for the purposes thereof and expressly waives any claim of improper venue
and any claim that such courts are an inconvenient forum.

 

14.         Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed to be
an original and all of which together shall be deemed to be one and the same agreement. A facsimile copy of this executed Agreement
shall be treated as an original.

 

15.         Gender.
All personal pronouns used in this Agreement shall be deemed to include the masculine, feminine and neuter genders.

 

16.         Placement
Agent. Certain of the Units have been offered by Seller through one or more placement agents, each of whom will be paid a commission
by Seller on the subscriptions for Units placed by such agent. The placement agents are not authorized to negotiate for or represent
the Seller in the Offering, but have served only to bring together Seller and Subscriber in this transaction.

 

    	-8-

    	 

    

 

IN WITNESS WHEREOF, Subscriber has
executed this Subscription Agreement as of ____________, 201_.

 

______________________________________________

Signature

 

Print Name:     __________________________________

 

Title if Entity: __________________________________

 

Address:         __________________________________

 

______________________________________________

 

Social Security or Tax ID No.: _____________________

 

Subscription Amount @ $0.17 per Unit: $____________

 

Number of shares of Stock: _______________________

 

Number of Warrants @ 50% coverage: ______________

 

    	 

    	 

    

 

Seller hereby accepts the foregoing subscription
subject to the terms and conditions hereof as of ______________, 201_.

 

IMMUDYNE, INC.

 

	By:	 
	Name: 	 
	Title:	 

 

    	 

    	 

    

 

Exhibit A

 

CERTIFICATE OF ACCREDITED INVESTOR STATUS

 

Except as may be indicated
by the undersigned below, the undersigned is an “accredited investor,” as that term is defined in Regulation D under
the Securities Act of 1933, as amended (the “Securities Act”). The undersigned has checked the box below indicating
the basis on which he, she or it is representing his, her or its status as an “accredited investor”:

 

		£	a bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association
or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;
a broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended; an insurance company as
defined in Section 2(13) of the Securities Act; an investment company registered under the Investment Company Act of 1940 or a
business development company as defined in Section 2(a)(48) of that Act; a small business investment company licensed by the U.S.
Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958; a plan established and
maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for
the benefit of its employees, and such plan has total assets in excess of $5,000,000; an employee benefit plan within the meaning
of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section
3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or
if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made
solely by persons that are “accredited investors”;

 

		£	a private business development company as defined in Section 202(a)(22) of the Investment Advisers
Act of 1940;

 

		£	an organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts
or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total
assets in excess of $5,000,000;

 

		£	a natural person whose individual net worth, or joint net worth with the undersigned’s spouse,
at the time of this purchase exceeds $1,000,000;

 

		£	a natural person who had an individual income in excess of $200,000 in each of the two most recent
years or joint income with the undersigned’s spouse in excess of $300,000 in each of those years and has a reasonable expectation
of reaching the same income level in the current year;

 

		£	a trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the securities offered, whose purchase is directed by a person who has such knowledge and experience in financial and business
matters that he, she or it is capable of evaluating the merits and risks of the prospective investment;

 

    	 

    	 

    

 

		£	an entity in which all of the equity holders are “accredited investors” by virtue of
their meeting one or more of the above standards; or

 

		£	an individual who is a director or executive officer of ImmuDyne, Inc.

 

IN WITNESS WHEREOF, the undersigned
has executed this Certificate of Accredited Investor Status effective as of the __ day of ___________, 201_.

 

	 	 
	 	Signature	 
	 	 	 
	 	Print Name:	 
	 	 	 
	 	Title if Entity: 	 

 

    	 

    	 

    

 

Exhibit B

 

WARRANT

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO RESTRICTIONS ON TRANSFER UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND STATE SECURITIES LAWS, AND MAY NOT BE
OFFERED FOR SALE, SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE APPLICABLE SECURITIES
LAWS OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL ARE BOTH REASONABLY SATISFACTORY TO THE COMPANY, HAS BEEN DELIVERED TO
THE COMPANY STATING THAT THE SECURITIES MAY BE TRANSFERRED WITHOUT SUCH REGISTRATION. IN ADDITION, THIS WARRANT MAY NOT BE TRANSFERRED
WITHOUT THE PRIOR CONSENT OF THE COMPANY.

 

VOID AFTER 5:00 P.M., NEW YORK TIME, ON
THE EXPIRATION DATE, AS DEFINED HEREIN, OR IF NOT A BUSINESS DAY, AS DEFINED HEREIN, AT 5:00 P.M., NEW YORK TIME, ON THE NEXT FOLLOWING
BUSINESS DAY.

 

WARRANT TO PURCHASE

 

SHARES OF COMMON STOCK

 

OF

 

IMMUDYNE, INC.

 

This certifies that,
for good and valuable consideration, ________________________ and its assigns (collectively, the “Warrantholder”),
are entitled to purchase from ImmuDyne, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”),
subject to the terms and conditions hereof, at any time on or after 5:00 p.m., New York time, on _________________ (the “Commencement
Date), and before 5:00 p.m., New York time on such day that is three (3) years after the Commencement Date (the “Expiration
Date), _________ shares of Common stock, $.01 par value (“Common Stock”), of the Company (the “Warrant Shares”),
subject to adjustment as provided herein, at a price of $0.40 per share (the “Exercise Price”) subject to adjustment
as provided herein (together with all other warrants issued on the date hereof and all other warrants that may be issued in its
or their places, the “Warrant”). If the Expiration Date falls on a Saturday, Sunday or other day on which banks in
the State of New York are authorized by law to remain closed, then the Expiration Date shall be the next succeeding day on which
banks in the State of New York are not authorized by law to remain closed (a “Business Day”).

 

    	 

    	 

    

 

ARTICLE 1

 

DURATION AND EXERCISE OF WARRANT

 

1.1          Duration
of Warrant. The Warrantholder may exercise this Warrant at any time and from time to time after 5:00 p.m., New York time, on
the Commencement Date, and before 5:00 p.m., New York time, on the Expiration Date. If this Warrant is not exercised on the Expiration
Date, it shall become void, and all rights hereunder shall thereupon cease.

 

1.2          Exercise
of Warrant.

 

(a)          Warrantholder
may exercise this Warrant, in whole only, by presentation and surrender of this Warrant to the Company at its corporate office
at 50 Spring Meadow Road, Mt. Kisco, New York 10549 or at the office of its stock transfer agent, Computershare Stock, 250 Royall
Street, Canton, MA 02021 with the Subscription Form annexed hereto duly executed and accompanied by payment of the full Exercise
Price for the Warrant Shares so exercised.

 

(b)          Upon
receipt of this Warrant with the Subscription Form fully executed and accompanied by payment of the Exercise Price for the Warrant
Shares, the Company shall cause to be issued one or more certificates for the Warrant Shares (adjusted to reflect the effect of
the provisions contained in Article 2 hereof, if any, and as provided in Section 1.4 hereof) in such denominations as are requested
for delivery to the Warrantholder, and the Company shall thereupon deliver such certificates to the Warrantholder.

 

The Warrantholder shall
not be deemed to be the holder of record of the shares of Common Stock issuable upon such exercise until the certificates representing
such shares of Common Stock shall be actually delivered to the Warrantholder. The Company may require the Warrantholder to make
such representations, and may place such legends on certificates representing the Warrant Shares, as may be reasonably required
in the opinion of counsel to the Company to permit the Warrant Shares to be issued without registration.

 

(c)          The
Company shall pay any and all stock transfer and similar taxes which may be payable in respect of the issuance of the Warrant Shares.

 

1.3          Reservation
of Shares. The Company hereby agrees that at all times there shall be reserved for issuance and delivery upon exercise of this
Warrant such number of shares of Common Stock or other shares of capital stock of the Company from time to time issuable upon exercise
of this Warrant. All such shares shall be duly authorized, and when issued upon such exercise, shall be validly issued, fully paid
and non-assessable, free and clear of all liens, security interests, charges and other encumbrances or restrictions on sale (except
as contemplated by Section 1.2 (b)) and free and clear of all preemptive rights.

 

1.4          Fractional
Shares. The Company shall not be required to issue any fraction of a share of its capital stock in connection with the exercise
of this Warrant, and in any case where the Warrantholder would, except for the provisions of this Section 1.4, be entitled under
the terms of this Warrant to receive a fraction of a share upon the exercise of this Warrant, the Company shall, upon the exercise
of this Warrant, pay to the Warrantholder an amount in cash equal to the fair market value of such fractional share as of the exercise
date, which shall be (i) if the Common Stock is listed on a national securities exchange or automated quotation system, the closing
sale or bid price for the Common Stock on the trading day preceding the day upon which the Warrant is exercised, or (ii) if the
stock is not so listed, the value as determined by the Board of Directors of the Company.

 

    	-2-

    	 

    

 

ARTICLE 2

 

ADJUSTMENT OF SHARES OF COMMON STOCK

PURCHASABLE AND OF EXERCISE PRICE

 

The Exercise Price and the number and kind
of Warrant Shares shall be subject to adjustment from time to time upon the happening of certain events as provided in this Article
2.

 

2.1          Adjustments.

 

(a)          If
at any time prior to the exercise of this Warrant, the Company shall fix a record date for the issuance or making of a distribution
to all holders of the Common Stock (including any such distribution to be made in connection with a consolidation or merger in
which the Company is to be the continuing corporation) of evidences of indebtedness, any other securities of the Company or any
cash property or other assets (excluding a standard combination, reclassification or recapitalization), the Exercise Price shall
be appropriately adjusted in favor of the Warrantholder.

 

(b)          If
at any time prior to the exercise of this Warrant, the Company shall make a distribution to all holders of the Common Stock of
stock of a subsidiary or securities convertible into or exercisable for such stock then in lieu of an adjustment in the Exercise
Price or the number of Warrant Shares purchasable upon the exercise of this Warrant, each Warrantholder, upon the exercise hereof
at any time after such distribution, shall be entitled to receive from the Company, such subsidiary or both, as the Company shall
determine, the stock or other securities to which such Warrantholder would have been entitled if such Warrantholder had exercised
this Warrant immediately prior thereto, all subject to further adjustment as provided in this Article 2, and the Company shall
reserve, for the life of the Warrant, such securities of such subsidiary or other corporation; provided, however, that no adjustment
in respect of dividends or interest on such stock or other securities shall be made during the term of this Warrant or upon its
exercise.

 

(c)          Whenever
the Exercise Price payable upon exercise of each Warrant is adjusted pursuant to one or more of paragraphs (a) and (b) of this
Section 2.1, the Warrant Shares shall simultaneously be appropriately adjusted in favor of the Warrantholder.

 

(d)          If
at any time the Company’s Board of Directors votes to split or reverse split the Common Stock of the Company, then the number
of Warrants and the exercise price shall be adjusted appropriately, to reflect such stock split or reverse split.

 

    	-3-

    	 

    

 

2.2          Form
of Warrant After Adjustments. The form of this Warrant need not be changed because of any adjustments in the Exercise Price
or the number or kind of the Warrant Shares, and Warrants theretofore or thereafter issued may continue to express the same price
and number and kind of shares as are stated in this Warrant, as initially issued.

 

ARTICLE 3

 

OTHER PROVISIONS RELATING TO RIGHTS OF
WARRANTHOLDER

 

3.1          No
Rights as Shareholders; Notice to Warrantholders. Nothing contained in this Warrant shall be construed as conferring upon the
Warrantholder or its transferees the right to vote or to receive dividends or to consent or to receive notice as a shareholder
in respect of any meeting of shareholders for the election of directors of the Company or of any other matter, or any rights whatsoever
as shareholders of the Company. The Company shall give notice to the Warrantholder by registered mail if at any time prior to the
expiration or exercise of the Warrant, any of the following events shall occur:

 

(a)          The
Company shall authorize the payment of any dividend payable in any securities upon shares of Common Stock or authorize the making
of any distribution (other than a cash dividend) to all holders of Common Stock;

 

(b)          The
Company shall authorize the issuance to all holders of Common Stock of any additional shares of Common Stock or Common Stock equivalents
or of rights, options or warrants to subscribe for or purchase Common Stock or Common Stock equivalents or of any other subscription
rights, options or warrants;

 

(c)          A
dissolution, liquidation or winding up of the Company shall be proposed; or

 

(d)          A
capital reorganization or reclassification of the Common Stock (other than a subdivision or combination of the outstanding Common
Stock and other than a change in the par value of the Common Stock) or any consolidation or merger of the Company with or into
another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not
result in any reclassification or change of Common Stock outstanding) or in the case of any sale or conveyance to another corporation
of the property of the Company as an entirety or substantially as an entirety. Such giving of notice shall be initiated (i) at
least 20 Business Days prior to the date fixed as a record date or effective date or the date of closing of the Company’s
stock transfer books for the determination of the shareholders entitled to such dividend, distribution or subscription rights,
or for the determination of the shareholders entitled to vote on such proposed merger, consolidation, sale, conveyance, dissolution,
liquidation or winding up. Such notice shall specify such record date or the date of closing the stock transfer books, as the case
may be. Failure to provide such notice shall not affect the validity of any action taken in connection with such dividend, distribution
or subscription rights, or proposed merger, consolidation, sale, conveyance, dissolution, liquidation or winding up.

 

    	-4-

    	 

    

 

3.2          Lost,
Stolen, Mutilated or Destroyed Warrants. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such
terms as to indemnity or otherwise as it may in its discretion impose (which shall, in case of a mutilated Warrant, include the
surrender thereof), issue a new Warrant of like denomination and tenor as, and in substitution for, this Warrant.

 

ARTICLE 4

 

SPLIT-UP, COMBINATION

EXCHANGE AND TRANSFER OF WARRANTS

 

4.1          Split-Up,
Combination and Exchange of Warrants. This Warrant may be split up, combined or exchanged for another Warrant or Warrants containing
the same terms to purchase a like aggregate number of Warrant Shares. If the Warrantholder desires to split up, combine or exchange
this Warrant, it shall make such request in writing delivered to the Company and shall surrender to the Company this Warrant and
any other Warrants to be so split-up, combined or exchanged. Upon any such surrender for a split-up, combination or exchange, the
Company shall execute and deliver to the person entitled thereto a Warrant or Warrants, as the case may be, as so requested. The
Company shall not be required to effect any split-up, combination or exchange which will result in the issuance of a Warrant entitling
the Warrantholder to purchase upon exercise a fraction of a share of Common Stock or a fractional Warrant. The Company may require
such Warrantholder to pay a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any split-up,
combination or exchange of Warrants.

 

4.2          Restrictions
on Transfer; Restrictive Legends. This Warrant may not be assigned or transferred without the prior written consent of the
Company, which consent will not be unreasonably withheld and compliance with other requirements of applicable law, including compliance
with applicable federal and state securities laws.

 

Except as otherwise
permitted by this section 4.2, each Warrant and each stock certificate for Warrant Shares and each stock certificate issued upon
the direct or indirect transfer thereof shall be stamped or otherwise imprinted with a legend in substantially the following appropriate
form:

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND STATE SECURITIES
LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE
APPLICABLE SECURITIES LAWS OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL ARE BOTH REASONABLY SATISFACTORY TO THE COMPANY,
HAS BEEN DELIVERED TO THE COMPANY STATING THAT THE SECURITIES MAY BE TRANSFERRED WITHOUT SUCH REGISTRATION.

 

    	-5-

    	 

    

 

Notwithstanding the
foregoing, the Warrantholder may require the Company to issue a stock certificate for Warrant Shares without a legend if such Warrant
Shares have been sold pursuant to Rule 144 under the Securities Act of 1933 or the Company has received an opinion of counsel reasonably
satisfactory to the Company that such registration is not required with respect to such Warrant Shares.

 

ARTICLE 5

 

OTHER MATTERS

 

5.1           Binding
Effect; Benefits. This Warrant shall be binding upon and inure to the benefit of the Company and its successors and assigns
and the Warrantholders. Nothing in this Warrant is intended or shall be construed to confer upon any person, other than the Company
and the Warrantholders, any right, remedy or claim under or by reason of this Warrant or any part hereof.

 

5.2           Integration/Entire
Agreement. This Warrant is intended by the parties as a final expression of their agreement and intended to be a complete and
exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein.
This Warrant supersedes all prior agreements and understandings between the parties with respect to such subject matter.

 

5.3           Amendments
and Waivers. The provisions of this Warrant, including the provisions of this sentence, may not be amended, modified or supplemented,
and waiver or consents to departures from the provisions hereof may not be given without the written consent of the Warrantholder
and the Company.

 

5.4           Governing
Law. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware.

 

5.5           Attorneys’
Fees. In any action or proceeding brought to enforce any provisions of this Warrant, or where any provision hereof is validly
asserted as a defense, the successful party shall be entitled to recover reasonable attorneys’ fees and disbursements in
addition to its costs and expenses and any other available remedy.

 

5.6           Notice.
Any notices or certificates by the Company to the Warrantholder and by the Warrantholder to the Company shall be deemed delivered
if in writing and delivered in person, by facsimile transmission, email or by registered mail (return receipt requested). Notices
to the Warrantholder should be addressed to it at the address designated by it in the records of the Company, or, if the Warrantholder
has designated, by notice in writing to the Company, any other address, to such other address. Notices to the Company should be
addressed to it at: 50 Spring Meadow Road, Mt. Kisco, New York 10549, Attn: Mr. Mark McLaughlin, fax 914-244-8576 or if the Company
has designated, by notice in writing to the Warrantholder, any other address, to such other address.

 

    	-6-

    	 

    

 

IN WITNESS WHEREOF, this Warrant has been duly executed
by the Company effective the ____ day of ___________, 201_.

 

IMMUDYNE, INC.

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

ATTEST:

 

	 	 	 
	Name:	 	 
	Title:	Secretary	 

 

    	 

    	 

    

 

ASSIGNMENT

(To be executed only upon assignment of
Warrant)

 

For value received,
_____________________, hereby sells, assigns and transfers unto ____________________________, the within Warrant, together with
all rights, title and interest therein, and does hereby irrevocably constitute and appoint ________________________, attorney,
to transfer said Warrant on the books of the within-named Company with respect to the number of Warrant Shares set forth below,
with full power of substitution in the premises:

 

	Name(s) of	 	 	 	 
	Assignee(s)	 	Address	 	No. of Warrant Shares
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

And if said number of Warrant Shares shall
not be all the Warrant Shares represented by the Warrant, a new Warrant is to be issued in the name of said undersigned for the
balance remaining of the Warrant Shares registered by said Warrant.

 

	Dated: _______________	Signature:
	 	 
	 	 
	 	 
	 	Note: The above signature should correspond exactly
	 	with the name on the face of this Warrant.

 

    	 

    	 

    

 

SUBSCRIPTION FORM

(To be executed upon exercise of Warrant)

 

IMMUDYNE, INC.:

 

The undersigned hereby
irrevocably elects to exercise the right of purchaser represented by the within Warrant, to purchase Warrant Shares and herewith
tenders payment of the Exercise Price in full for ___________________________ of the Warrant Shares in the form of cash or a certified
or official bank check to the order of ImmuDyne, Inc. in the amount of $__________________________ in accordance with the terms
of this Warrant.

 

Please issue a certificate or certificates
for such Common Stock in the name of, and pay any cash for fractional share to:

 

Name: __________________________________

 

________________________________________

 

________________________________________

 

________________________________________

(Print Name, Address and Social Security No.)

 

Signature: _________________________________________

 

Note:    The above signature should correspond
exactly with the name on the first page of this Warrant Certificate or with the name of the assignee appearing in the assignment
form.EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (“Agreement")
is made effective as of October 12, 2012 (the “New Effective Date”), by and between IMMUDYNE, INC., a Delaware
corporation (the "Company"), and Mark McLaughlin, an individual and resident of the State of New York (the "Executive").

 

The Company and the
Executive are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."

 

WlTNESSETH:

   

WHEREAS, the Company desires to employ, and the
Executive agrees to work in the employ of the Company;

 

WHEREAS, the Parties
hereto desire to set forth the terms of Executive’s employment with the Company; and

 

WHEREAS, the Parties
desire for this Agreement to supersede and replace in its entirety the original employment agreement (the “Original Agreement”)
of the Executive entered into on April 20, 2011 (the “Original Effective Date”), by and between the Company and Mark
McLaughlin DBA McLaughlin International, Inc.

 

NOW, THEREFORE, for
and in consideration of the mutual promises, covenants and obligations contained, the Company and Executive hereby agree as follows:

 

		1.	Employment and Location. The Company hereby employs Executive, and Executive hereby accepts
employment by the Company, on the terms and conditions hereinafter set forth. Given the Executive's personal circumstances, and
circumstances at the Company, Executive shall not be required to relocate.

 

		2.	Executive's Duties. Executive will serve as President and Chief Executive Officer of the
Company, and serve as a Director of the Company. Executive's duties shall include those which are designated or assigned to him
from time to time by the Board of Directors of the Company or the By-laws of the Company, provided those duties are of the type
customarily discharged by a person holding the same or similar offices in a company of similar size and operations as the Company.
Executive shall devote his entire time, attention and energy to the business of the Company and shall diligently pursue its best
interests.

 

    	 

    	 

    

 

		3.	Term of Employment. Subject to the provisions for termination hereof; the original term
of this Agreement shall commence as of the date of the Original Effective Date and shall continue for a term of five (5) years.
Subsections 6(f) through 6(j) and Sections 7 through 20 of this Agreement shall survive termination hereof for any reason whatsoever.

 

		4.	Compensation. For all services rendered by Executive hereunder on behalf of the Company,
and the covenants and agreements of Executive set forth herein (including without limitation the covenant not to compete set forth
in Section 8 hereof), the Company agrees to pay to Executive, and Executive agrees to accept, the following compensation:

 

		a)	an annual salary of $134,000; and

 

		(b)	an annual incentive bonus award amounting to five percent (5%) of the Pre-Tax Earnings of the Company,
payable within 90 days after the end of each semi-annual fiscal year ended after the effective date of this Agreement. "Pre
Tax Earnings" shall mean earnings of the Company determined prior to payment or deduction of federal or state income taxes,
determined in accordance with generally accepted accounting principles, consistently applied; and

 

		(c)	a ten year, fully vested option for 800,000 shares of Common Stock of the Company, such shares
purchasable or exercisable on a cashless basis at an exercise price of $0.20 (twenty cents) per share; and

 

		(c)	a ten year, fully vested option for 1,000,000 shares of Common Stock of the Company, such shares
purchasable or exercisable on a cashless basis at an exercise price of $0.20 (twenty cents) per share; and

 

		(d)	a ten year fully vested option for another 500,000 shares of Common Stock of the Company, such
shares purchasable or exercisable on a cashless basis at an exercise price of $0.40 (forty cents) per share; and

 

		(e)	Should the revenues of the Company reach $5,000,000 in any fiscal year, a ten year fully vested
option for 500,000 shares of Common Stock of the Company, such shares purchasable or exercisable on a cashless basis at an exercise
price of $0.40 (forty cents) per share; and

 

    	 

    	 

    

 

		(f)	Should the fiscal year revenues of the Company reach $10,000,000, a ten year fully vested option
for an additional 500,000 shares of Common Stock of the Company, such shares purchasable or exercisable on a cashless basis at
an exercise price of $0.80 (eighty cents) per share; and

 

		(g)	If the Company is prevented from issuing any of options or the stock due to pending litigation,
or for any other reason, then the expiration date(s) will commence (or recommence, if applicable) when the Company’s options
or the stock relating thereto are no longer subject to current litigation, or any other contingency prohibiting the Company from
issuing said options or stock. Additionally, if the Company should merge into or be acquired by another company, any options or
stock not granted up to the date of merger or acquisition will be granted to and will be immediately exercisable by Executive on
the business day immediately preceding the merger or acquisition at $0.40 (forty cents) per share, or the preceding average 30
day market price of the Company's stock prior to the announcement of such merger or acquisition, whichever price is lower. If the
effective day for establishing the exercise price for the options is a non-working day, the working day preceding such date shall
be the effective date. All shares resulting from the exercise of options shall have the same rights as all other shares of the
Company's capital stock. Further, if the Company should split its stock prior to the granting or exercise of said options, then
the options shall be split in a similar manner and the exercise price shall be adjusted to prevent any dilution or increase in
Executive’s interest in the Company's stock once the options are granted or exercised. Lastly, Executive or his Estate will
have the right to assign all his options, and the rights to his future options. Executive’s options and the rights to his
future options do not terminate with his death. The options may be exercised by his heirs and his assigns and their heirs; and

 

		(h)	Annual paid vacation of four weeks; and

 

		(i)	Prompt reimbursement of all reasonable expenses incurred by Executive in the performance of Executive’s
duties during the term of this Agreement, subject to the presentation of appropriate vouchers and receipts in accordance with the
Company's policies.

 

		5.	Additional Benefits. Executive shall be entitled to participate in or receive benefits under
all benefit plans (including health insurance for himself and his family) and other programs generally available to employees of
the Company to the extent that Executive’s position, tenure, salary, age, health and other qualifications make Executive
eligible to participate, subject to the rules and regulations applicable thereto.

 

    	 

    	 

    

 

		6.	Covenants of Executive. For and in consideration of the employment herein contemplated and
the consideration paid or promised to be paid by the Company, Executive does hereby covenant, agree and promise that during the
term hereof, and thereafter to the extent specifically provided in this Agreement:

 

		(a)	Executive will not actively engage, directly or indirectly, in any other business or venture that
competes with the Company except at the direction or upon the written approval of the Company;

 

		(b)	Executive will not engage, directly or indirectly, in the ownership, management, operation or control
of, or employment by, any business of the type and character engaged in by the Company or any of its subsidiaries. Executive may
make personal investments in public companies, such as those made through or recommended by a stock broker;

 

		(c)	Executive will truthfully and accurately make, maintain and preserve all records and reports that
the Company may from time to time reasonably request or require;

 

		(d)	Executive will obey all rules, regulations and reasonable special instructions applicable to Executive,
and will be loyal and faithful to the Company at all times, constantly endeavoring to improve Executive's ability and knowledge
of the business in an effort to increase the value of Executive's services to the mutual benefit of the Parties;

 

		(e)	Executive will make available to the Company any and all of the information of which Executive
has knowledge relating to the business of the Company or any of the Company's other subsidiaries and will make all suggestions
and recommendations which Executive feels will be of benefit to the Company;

 

		(f)	Executive will fully account for all money, records, goods, wares and merchandise or other property
belonging to the Company of which Executive has custody, and will pay over and deliver the same promptly whenever and however he
may be reasonably directed to do so;

 

    	 

    	 

    

 

		(g)	Executive recognizes that during the course of Executive’s previous and current employment
with the Company, Executive has had and will have access to, and that there has been. and will be disclosed to him, information
of a proprietary nature owned by the Company, including but not limited to records, customer and supplier lists and information,
pricing information, data, formulae, design information and specifications, inventions, processes and methods, which is of a confidential
or trade secret nature, and which has great value to the Company and is a substantial basis and foundation upon which the business
of the Company is predicated. Executive acknowledges that except for Executive's employment and the fulfillment of the duties assigned
to Executive, Executive would not have had and would not have access to such information, and Executive agrees that any and all
confidential knowledge or information which may have been or may be obtained by or disclosed to Executive in the course of Executive’s
employment with the Company, including but not limited to the information hereinabove set forth (collectively, the "Information"),
will be held inviolate by Executive, that Executive will conceal the same from any and all other persons, including but not limited
to competitors of the Company and its subsidiaries, and that Executive will not impart the Information or any such knowledge acquired
by Executive as an officer, director or employee of the Company to anyone, either during Executive's employment by the Company
or thereafter, except to employees or agents of the Company and its subsidiaries on a strict need-to-know basis in the performance
of their duties as employees or agents of the Company or one of its subsidiaries. Executive further agrees that during the term
of this Agreement and thereafter, Executive will not use the Information in competing with the Company, or in any other manner
to Executive's benefit or to the detriment of the Company or its subsidiaries;

 

		(h)	Executive agrees that upon termination of Executive's employment hereunder Executive will immediately
surrender and turn over to the Company all books, records, forms, specifications, formulae, data, processes, papers and writings
related to the business of the Company, and all other property belonging to the Company, together with all copies of the foregoing,
it being understood and agreed that the same are the sole property, directly or indirectly, of the Company; and

 

    	 

    	 

    

 

		(i)	Executive agrees that all ideas, concepts, processes, discoveries, devices, machines, tools, materials,
designs, improvements, inventions and other things of value (hereinafter collectively referred to as "intangible rights"),
whether patentable or not, which are conceived, made, invented or suggested either by Executive alone or in collaboration with
others during the term of Executive's employment, and whether or not during regular working hours, shall be promptly disclosed
in writing to the Company and shall be the sole and exclusive property of the Company. Executive hereby assigns all of Executive’s
right, title and interest in and to all such intangible rights to the Company and its successors or assigns. In the event that
any of said intangible rights shall be deemed by the Company to be patentable or otherwise able to be registered under any federal,
state or foreign law, Executive further agrees that at the request and expense of the Company, he will execute all documents and
do all things necessary, advisable or proper to obtain patents therefore or registration thereof; and to vest in the Company full
title thereto.

 

		(j)	Executive understands and acknowledges that the securities of the Company are publicly traded and
subject to the Securities Act of 1933 and the Securities Exchange Act of 1934. As a result, Executive acknowledges and agrees that
(i) he is required under applicable securities laws to refrain from trading in securities of the Company while in possession of
material nonpublic information and to refrain from. disclosing any material nonpublic information to anyone except as permitted
by this Agreement in connection with the performance of Executive’s duties hereunder, and (ii) he will communicate to any
person to whom he communicates any material nonpublic information that such information is material nonpublic information and that
the trading and disclosure restrictions in clause (i) above also apply to such person.

 

		7.	Termination of Employment for Cause. The Company may terminate the employment of Executive
if the Board of the Directors of the Company determines that Executive has:

 

		(a)	materially breached any provision hereof or habitually neglected the duties which Executive was
required to perform under any provision of this Agreement;

 

		(b)	misappropriated funds or property of the Company or otherwise engaged in acts of dishonesty, fraud,
misrepresentation or other acts of moral turpitude, even if not in connection with the performance of Executive's duties hereunder,
which could reasonably be expected to result in serious prejudice to the interests of the Company if Executive were retained as
an employee;

 

    	 

    	 

    

 

		(c)	secured any personal profit not completely disclosed to and approved by the Company in connection
with any transaction entered into on behalf of or with the Company or any affiliate of the Company;

 

		(d)	died, or become and remained incapacitated (either physically, mentally or otherwise) for a period
of ninety (90) consecutive days such that Executive is not able to substantially perform Executive's duties hereunder; or

 

		(e)	failed to carry out and perform duties assigned to Executive in accordance with the terms hereof
in a manner acceptable to the Board of Directors of the Company after a written demand for substantial performance is delivered
to Executive which identifies the manner in which Executive has not substantially performed Executive's duties, and provided further
that Executive shall be given a reasonable opportunity to cure such failure.

 

For purposes of this section, no
act, or failure to act, on the Executive's part shall be considered "willful" unless done, or omitted to be done, by
him not in good faith and without reasonable belief that his action or omission was in the best interest of the Company. Notwithstanding
the foregoing, the Executive shall not be deemed to have been terminated For Cause under subsection (a) without (i) reasonable
notice to the Executive setting forth the reasons for the Company's intention to Terminate For Cause, (ii) an opportunity for the
Executive, together with his counsel, to be heard before the Board of Directors, and (iii) delivery to the Executive of a notice
of termination from the Board of Directors of the Company, finding that, in the good faith opinion of the Board of Directors, the
Executive was guilty of conduct set forth above in clause (a) of the preceding sentence and specifying the particulars thereof
in detail. In the event of termination of Executive's employment for cause, Executive shall be entitled to retain the options for
shares which have not been previously purchased, salary through the date of termination and reimbursement of expenses properly
incurred but not yet reimbursed.

 

    	 

    	 

    

 

		8.	Covenant Not to Compete.· The Executive recognizes that the Company has business
good will and other legitimate business interests which must be protected in connection with and in addition to the Information,
and therefore, in exchange for access to the Information, the specialized training and instruction which the Company will provide,
the Company's agreement to employ the Executive on the terms and conditions set forth herein, and the promotion and advertisement
by the Company of Executive's skill, ability and value in the Company's business, the Executive agrees that during the term commencing
with the date of employment and ending three years after the date Executive's employment, Executive will not, without the prior
written consent of the Company, engage, directly or indirectly, in any business that competes with the Company or any of its subsidiaries
in any territory in which the Company or any of its subsidiaries conducts business (determined as of the last date of Executive's
employment). It is mutually understood and agreed that if any of the provisions relating to the scope time or territory in this
Section 8 are more extensive than is enforceable under applicable laws or are broader than necessary to protect the good will and
legitimate business interests of the Company, then the Parties agree that they will reduce the degree and extent of such provisions
by whatever minimal amount is necessary to bring such provisions within the am bit of enforceability under applicable law.

 

		9.	Injunctive Relief. The Parties acknowledge that the remedies at law for breach of Executive's
covenants contained in Sections 6 and 8 of the Agreement are inadequate, and they agree that the Company shall be entitled, at
its election, to injunctive relief (without the necessity of posting bond against such breach or attempted breach), and to specific
performance of said covenants in addition to any other remedies at law or equity that may be available to the Company.

 

		10.	Business Opportunities. For as long as the Executive shall be employed by the Company and
thereafter with respect to any business opportunities learned about during the time of Executive's employment by the Company, the
Executive agrees that with respect to any future business opportunity or other new and future business proposal which is offered
to, or comes to the attention of, the Executive and which is in any way related to or connected with, the business of the Company
or its affiliates, the Company shall have the right to take advantage of such business opportunity or other business proposal for
its own benefit. The Executive agrees to promptly deliver notice to the Chairman of the Board of Directors or the Chief Financial
Officer of the Company in writing of the existence of such opportunity or proposal, and the Executive may take advantage of such
opportunity only if the Company does not elect to exercise its right to take advantage of such opportunity and if the pursuit thereof
would not otherwise violate any provision of this Agreement.

 

    	 

    	 

    

 

		11.	Right of Offset. To the extent permitted by applicable law, all amounts due and owing to
Executive hereunder shall be subject to offset by the Company to the extent of any damages incurred by Executive’s breach
of this Agreement. Executive acknowledges and agrees that but for the right of offset contained in this Agreement, the Company
would not have hired Executive nor entered into this Employment Agreement.

 

		12.	Obligations of Executive. The obligations of Executive hereunder are personal and may not
be transferred or delegated by Executive.

 

		13.	Amendment and Waiver. Except for the options retained by Executive as described in Section
23 of this Agreement, this instrument contains the entire agreement of the Parties and supersedes and replaces any prior employment
agreements between the Company or any affiliate and Executive, which prior employment agreements (if any) are hereby terminated,
effective as of the commencement date of this Agreement, by mutual agreement of the Parties. This Agreement may not be changed
orally but only by written documents signed by the Party against whom enforcement of any waiver, change, modification, extension
or discharge is sought; however, the amount of compensation to be paid to Executive for services to be performed for the Company
hereunder may be changed from time to time by the Parties by written agreement without in any other way modifying, changing or
affecting this Agreement or the performance by Executive of any of the duties of his employment with the Company. Any such written
agreement shall be, and shall be conclusively deemed to be, a ratification and confirmation of this Agreement, except as expressly
set forth in such written amendment. The waiver by any Party of a breach of any provision of this Agreement shall not operate as
or be construed to be a waiver of any subsequent breach thereof, nor of any breach of any other term or provision of this Agreement.

 

		14.	Notice. All notices and other communications hereunder shall be in writing and shall be
deemed duly delivered (i) three business days after being received by registered or certified mail, return receipt requested, postage
prepaid, or (ii) three business days after being sent for next business day delivery, fees prepaid, via a reputable nationwide
overnight courier service, in the case of the Company, to its principal office address, and in the case of Executive, to Executive's
residence address as shown on the records of the Company, or may be given by personal delivery thereof.

 

    	 

    	 

    

 

		15.	Severability. Whenever possible, each provision of this Agreement shall be interpreted in
such manner as to be valid and enforceable under applicable law, but if any provision of this Agreement shall be invalid, unenforceable
or prohibited by applicable law, then in lieu of declaring such provision invalid or unenforceable, to the extent permitted by
law (a) the Parties agree that they will amend such provision to the minimal extent necessary to bring such provision within the
ambit of enforceability, and (b) any court of competent jurisdiction may, at the request of either party, revise, reconstruct or
reform such provision in a manner sufficient to cause it to be valid and enforceable.

 

		16.	Force Majeure. Neither of the Parties shall be liable to the other for any delay or failure
to perform hereunder, which delay or failure is due to causes beyond the control of said Party, including, but not limited to:
acts of God; acts of the public enemy; acts of the United States of America or any state, territory or political subdivision thereof
or of the District of Columbia; fires; floods; epidemics, quarantine restrictions; strike or freight embargoes. Notwithstanding
the foregoing provisions of this Section 18, in every case the delay or failure to perform must be beyond the control and without
the fault or negligence of the Party claiming excusable delay.

 

		17.	Authority to Contract. The Company warrants and represents that it has full authority to
enter into this Agreement and to consummate the transactions contemplated hereby and that this Agreement is not in conflict with
any other agreement to which the Company is a party or by which it may be bound. The Company hereto further warrants and represents
that the individuals executing this Agreement on behalf of the Company have the full power and authority to bind the Company to
the terms hereof and have been authorized to do so in accordance with the Company's corporate organization.

 

		18.	Mediation. In the event of any dispute arising under or pursuant to this Agreement, the
Parties agree to attempt to resolve the dispute in a commercially reasonable fashion before instituting any arbitration or litigation
(with the exception of emergency injunctive relief as set forth in Paragraph 9). If the Parties are unable to resolve the dispute
within thirty (30) days, then the Parties agree to mediate the dispute with a mutually agreed upon mediator. If the Parties cannot
agree upon a mediator within ten (10) days after either party shall first request commencement of mediation, each party will select
a mediator within five (5) days thereof, and those mediators shall select the mediator to be used. The mediation shall be scheduled
within thirty (30) days following the selection of the mediator. If the mediation does not resolve the dispute, then Paragraph
20 shall apply. The Parties further agree that any applicable statute of limitations will be tolled for the period of time from
the date mediation is requested until 14 days following the mediation.

 

    	 

    	 

    

 

		19.	Recovery of Litigation Costs. If any legal action or other proceeding is brought for the
enforcement of this Agreement or any agreement or instrument delivered under or in connection with this Agreement, or because of
an alleged dispute, breach, default or misrepresentation in connection with any of the provisions of this Agreement, the successful
or prevailing Party or Parties shall be entitled to recover reasonable attorneys' fees and other costs incurred in that action
or proceeding, in addition to any other relief to which it or they may be entitled.

 

		20.	Arbitration. Any and all disputes or controversies whether of law or fact and of any nature
whatsoever arising from or respecting this Agreement shall be decided by arbitration by the American Arbitration Association in
accordance with its Commercial Rules except as modified herein.

 

		(a)	The arbitrator shall be elected as follows: in the event the Company and the Executive agree on
one arbitrator, the arbitration shall be conducted by such arbitrator. In the event the Company and the Executive do not so agree,
the Company and the Executive shall each select one independent, qualified arbitrator and the two arbitrators so selected shall
select the third arbitrator (the arbitrator(s) are herein referred to as the "Panel"). The Company reserves the right
to object to any individual arbitrator who shall be employed by or affiliated with a competing organization.

 

		(b)	Arbitration shall take place at Houston, Texas, or any other location mutually agreeable to the
Parties. At the request of either Party, arbitration proceedings will be conducted in the utmost secrecy; in such case all documents,
testimony and records shall be received, heard and maintained by the arbitrators in secrecy, available for inspection only by the
Company or the Executive and their respective attorneys and their respective experts who shall agree in advance and in writing
to receive all such information in secrecy until such information shall become generally known. The Panel shall be able to award
any and all relief, including relief of an equitable nature, provided that punitive damages shall not be awarded. The award rendered
by the Panel may be enforceable in any court having jurisdiction thereof.

 

		(c)	Reasonable notice of the time and place of arbitration shall be given to all Parties and any interested
persons as shall be required by law.

 

    	 

    	 

    

 

		21.	Governing Law. This Agreement and the rights and obligations of the Parties shall be governed
by and construed and enforced in accordance with the substantive laws (but not the rules governing conflicts of laws) of the State
of Texas.

 

		22.	Multiple Counterparts. This Agreement may be executed in multiple counterparts each of which
shall be deemed to be an original but all of which together shall constitute but one instrument.

 

		23.	Prior Employment Agreements. The Company represents and warrants to Executive, and Executive
represents and warrants to the Company, that Executive and the Company have fulfilled all of the terms and conditions of all prior
employment agreements to which Executive may be or has been a party.

 

EXECUTED as of the
day and year first above set forth.

 

	IMMUDYNE, INC.	EXECUTIVE
	 	 
	By: /s/ Anthony Burzzese	/s/ Mark McLaughlin
	 	 
	Anthony Bruzzese	Mark McLaughlin
	 	 
	Chairman of the Board of Directors

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]